Status:
COMPLETED
Procoagulant Activity in Patients With Community Acquired Pneumonia, Pleural Effusion and Empyema
Lead Sponsor:
Meir Medical Center
Conditions:
Pneumonia
Pleural Effusion
Eligibility:
All Genders
18+ years
Brief Summary
Community acquired pneumonia (CAP) is still one of the most important causes of morbidity in adults. (1) In severe cases, parapneumonic effusions or empyema may develop. In these patients, a transitio...
Detailed Description
Community acquired pneumonia (CAP) is still one of the most important causes of morbidity in adults. (1) In severe cases, parapneumonic effusions or empyema may develop. In these patients, a transitio...
Eligibility Criteria
Inclusion
- All patients that will be admitted with CAP to the pulmonary department in Meir Medical Center and have no exclusion criteria will be included in the study.
Exclusion
- Patients younger than 18 years old
- Patients with anticoagulant treatment, primary coagulopathy, nephrotic syndrome, surgery, other infection in the month preceding the study, an abnormal liver or renal function test(s), a history of deep vein thrombosis in the last year or patients with acute coronary syndrome.
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT01178580
Start Date
November 1 2010
End Date
August 1 2011
Last Update
September 7 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pulmonary department, Meir Medical Center
Kfar Saba, Israel, Israel, 49100